Use a validated high-throughput screening and fractionation platform with a repository of 11,000 South African plant samples to identify environmentally friendly bioactive compounds active against pesticide-resistant lepidoptera, hoppers, thrips, and mites. The workflow combines biodiversity-driven selection, high-throughput bioassays, and bioactivity-based molecular networking to dereplicate inactive material and accelerate isolation and characterization of lead insecticidal candidates, with eco-toxicology and mode-of-action studies planned to support next-generation crop protection development.
This offering provides access to a validated natural product discovery platform built around a large and diverse plant repository, comprising over 11,000 unique dry ground plant samples. The platform enables the rapid identification of novel insecticidal compounds that are selectively potent against major agricultural pests, including pesticide-resistant lepidoptera, hoppers, thrips, and mites. By combining biodiversity-driven sample selection with high-throughput bioassay screening and bioactivity-based molecular networking, the approach accelerates the path from raw plant material to characterized lead compounds. The result is a discovery engine for environmentally friendly crop protection agents addressing critical resistance challenges in modern agriculture.
The underlying high-throughput screening and fractionation methodology is validated, having successfully supported the discovery of bioactive compounds in antiviral programs. The repository of 11,000 plant samples is established and accessible. Future validation will proceed through a structured eight-step pipeline: selection of candidate species, extraction and fractionation, primary screening against target pests, bioactivity-guided molecular networking, compound isolation, secondary screening of pure compounds, eco-toxicology profiling, and mode-of-action determination. Pest-specific bioassays are proposed to be conducted as part of the advancement plan toward lead optimization and potential commercial development in crop protection.
UP is a comprehensive, multi‑campus public research university in Pretoria with a broad disciplinary base and significant postgraduate activity. Industry engages through co‑located, large‑scale labs at the Engineering 4.0 campus—home to national reference and training facilities developed with SANRAL and partners—and through clinical pathways via Steve Biko Academic Hospital. For streamlined collaboration, Enterprises University of Pretoria serves as a single contracting gateway for contract research and consulting, while a dedicated Technology Transfer Office manages IP and licensing. Research is supported by South Africa’s National Research Foundation and the South African Medical Research Council, alongside international sponsors. Startup creation is enabled by the on‑campus TuksNovation incubator.